Contrast agents for MRA: Future directions

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 314-316

  Knopp, M V ^a   Von Tengg Kobligk, H ^a   Floemer, F ^a   Schoenberg, S O ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Contrast agents; MR angiography

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOBUTROL; GADOFOSVESET; GADOLINIUM CHELATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONTRAST ENHANCEMENT; EXTRACELLULAR SPACE; FIRST PASS EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; STEADY STATE; TISSUE SPECIFICITY;

CONTRAST MEDIA; FORECASTING; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY;

EID: 0032853901     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<314::AID-JMRI13>3.0.CO;2-Y     Document Type: Review

References (20)

1. Runge V M, Knopp MV. Off-label use and reimbursement for contrast media in MR. J Magn Reson Imaging 1999;10:000-000.
2. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191:155-164.
3. Debatin JF, Leung DA, Wildermuth S, Holtz D, McKinnon GC. Advances in vascular echoplanar imaging. Cardiovasc Intervent Radiol 1995;18:277-287.
4. Maki JH, Chenevert TL, Prince MR. Contrast-enhanced MR angiography. Abdom Imaging 1998;23:469-484.
5. Bongartz GM, Boos M, Winter K, et al. Clinical utility of contrast-enhanced MR angiography. Eur Radiol 1997;7(suppl 5):178-186.
6. Knopp M, Kauczor HU, Knopp MA, et al. Effects of viscosity, cannula size and temperature in mechanical contrast media administration in CT and magnetic resonance tomography. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1995;163:259-264.
7. Schoenberg SO, Knopp MV, Prince MR, Londy F, Knopp MA. Arterial phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries: strategies for timing and contrast media injection. Invest Radiol 1998;33:506-514
8. Vogler H, Platzek J, Schuhmann GG, et al. Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging. Eur J Radiol 1995;21:1-10.
9. Staks T, Schuhmann GG, Frenzel T, et al. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 1994;29:709-715.
10. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
11. Knopp MV, Schoenberg SO, Rehm C, et al. Comparison of the efficacy of Gd-BOPTA and Gd-DTPA for MR Angiography: a phase I pilot study. In: Proceding of the ISMRM. Sydney, 1998. p 174.
12. Spinazzi A, Lorusso V, Pirovano G, Kirchin MA. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with Gd-BOPTA: results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers. Acta Radiol 1999;6: 282-291.
13. th Annual Meeting, Philadelphia, 1999. p 1208.
14. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207: 529-538.
15. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207:539-544.
16. Koenig SH, Kellar KE. Blood-pool contrast agents for MRI: a critical evaluation. Acad Radiol 1998;5(suppl 1):200-205.
17. Wolf GL, Halavaara JT. Basic principles of MR contrast agents, Magn Reson Imaging Clin N Am 1996;4:1-10.
18. Wildermuth S, Dubno B, Romanowski BJ, et al. Open-label, phase 1 trial of a new blood pool contrast agent (NC100150) in 12 healthy volunteers: safety and vascular imaging characteristics. Proceedings of the 6th meeting of the ISMRM, Sydney, 1998; 171.
19. Saeed M, Wendland MF, Engelbrecht M, Sakuma H, Higgins CB. Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities. Eur Radiol 1998;8:1047-1053.
20. Taylor AM, Panting JR, Keegan J, et al. Safety and preliminary findings with the intravascular contrast agent NC100150 Injection for MR coronary angiography. J Magn Reson Imaging 1999;9:220-227.